Discover Great Companies Discover Great Clients
Popularity  8.6万   |   Followers  54   |   Likes  33   |   Feedback  84 Claim this company

Virtue over the world, medicine benefits all

No.122 Chongqing Popularity Ranking No.25 Yubei District No.1 Rubber Industrial No.1 Health Products No.2 TCM Decoction Pieces No.2 Chinese Patent Medicines No.3 Zhong Pharmaceuticals No.3 Nong Ye Chan Industries Chemical No.3 APIs No.3 Chinese Medicinal Materials No.4 Sheng Wu Ke Ji / Biotechnology Engineering No.4 Peptides No.5 Health No.5 Gong Cheng Yan Jiu Center AAA级信用企业 国家重点新产品 农业产业化国家重点龙头企业 国家扶贫龙头企业 中国名优产品 高新技术企业 GMP认证
More

Company Overview

  • Nature: Private Enterprise Size: 1000-4999 employees Founded: 32年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Chongqing Xi'er'an Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #122 in Chongqing by popularity Ranked #1 in Chongqing Rubber Industrial Company by popularity Ranked #1 in Chongqing Health Products Company by popularity Ranked #2 in Chongqing TCM Decoction Pieces Company by popularity Ranked #2 in Chongqing Chinese Patent Medicines Company by popularity
  • Honors: 2023中国中成药企业100强 AAA级信用企业 国家重点新产品 According to algorithm
  • Salary: 52.3% of positions earn 10-20K, In 2026 vs last yeargrew by 5%.。Master's salary: ¥26.1K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 36.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 16.1%, "Computer/Network/Technology": 9.3%。
  • Recruiting: In 2026 vs 2025decreased by 16%. Demand for highly educated talent: Master's: 10.
  • Requirement: Education: 本科 leads with 49.6%. Experience: 3-5年 leads with 36.3%.
  • Region: Distributed across 25 regions, 重庆: 43.2%, 广安: 15.3%, 广州: 5.4%, 昆明: 1.8%.

About the Company

[Summary] Virtue over the world, medicine benefits all

Chongqing Xi'er'an Pharmaceutical Co., Ltd. originated from the 'Wu Shufang Aroma Room' in the 37th year of Emperor Kangxi (AD 1698). 'Wu Shufang' is a recognized China Time-honored Brand and a Chongqing Intangible Cultural Heritage.

Xi'er'an Pharmaceutical has always adhered to the corporate philosophy of 'Virtue over the world, medicine benefits all'. It has now developed into a comprehensive pharmaceutical enterprise integrating R&D, production, and sales, with total assets of 3 billion yuan. The enterprise has been successively rated as a National High-tech Enterprise, a National Intellectual Property Demonstration Enterprise, a Leading Enterprise of the National Bio-industry Base, a National Key Leading Enterprise in Agricultural Industrialization, as well as a 'National-level Green Factory' certified by the Ministry of Industry and Information Technology.

The production base of Xi'er'an is located in the Hechuan District Industrial Park of Chongqing, covering an area of 400 mu. It has 18 production lines for traditional Chinese medicines (TCM) of different dosage forms, all of which have passed the new national GMP compliance checks, with an annual output of 5,000 tons of proprietary Chinese medicines. The enterprise vigorously promotes the construction of intelligent manufacturing, with a total investment of 1.2 billion yuan. It has built a digital production plant for proprietary Chinese medicines, establishing a data-driven intelligent manufacturing system, achieving intelligent production processes, lean operation management, and scientific environmental protection. It has been awarded the 'National-level Green Factory' and 'Chongqing Digital Workshop'.

The enterprise is committed to building a community of shared interests between manufacturers and distributors, implementing an omnichannel marketing strategy, and achieving systematic development. The sales network covers all provinces, autonomous regions, and municipalities in China except Hong Kong, Macao, Taiwan, and Tibet. It has formed a sales pattern with deep cultivation from general hospitals in provincial capitals to district and county hospitals, township health centers, individual clinics, and retail pharmacies. It has established product lines with market competitive advantages in fields such as rheumatology, orthopedics, dermatology, respiratory medicine, cardiovascular and cerebrovascular medicine, pediatrics, gynecology, and sleep products.

As of the end of 2024, the enterprise has 101 varieties listed in the 'National Basic Medical Insurance Drug Catalog', 31 varieties in the 'National Essential Drug List', and 29 exclusive varieties. Some key products such as Shexiang Zhuifeng Zhitong Ointment, Dieda Qili Tablets, and Jinchan Zhiyang Capsules are exclusive or patented products, which have won national or provincial science and technology progress awards, Chongqing Major New Products, Chongqing High-tech Products, and other honors. Currently, two varieties, Shexiang ZhuiFeng ZhiTong Ointment and Dieda Qili Tablets, are national TCM protection varieties (valid until January 19, 2030); a total of 15 varieties have obtained national TCM variety protection.

Xi'er'an adheres to the scientific research strategy of 'Technology serves humanity, innovation promotes development', follows the R&D policy of 'combining imitation and innovation, and valuing both drugs and health products', and forms an R&D pattern of 'screening a batch, developing a batch, and reserving a batch'. The enterprise's R&D institution, Chongqing Sike Pharmaceutical Research Institute Co., Ltd., is a National Enterprise Technology Center, a Chongqing Postdoctoral Research Workstation, a Chongqing TCM Preparation Process Engineering Technology Research Center, and a Chongqing Industrial and Information Technology Key Laboratory of TCM Rubber Plasters.

The enterprise actively explores mechanisms of joint education, school-enterprise co-construction, and industry-education integration. It jointly builds a 'Biopharmaceutical Collaborative Innovation Center' to promote scientific and technological exchanges and cooperation among universities, research institutes, and enterprises, and to facilitate the transformation of innovative achievements. Cooperative partners include: China Academy of Chinese Medical Sciences, Academy of Military Medical Sciences, Beijing University of Chinese Medicine, Georgia Institute of Technology, West China Medical University, Army Medical University, Chengdu University of TCM, Chongqing Medical University, Chongqing Academy of Chinese Materia Medica, etc.

Up to now, the enterprise has a total of 213 drug production approvals; it has accumulated 200 Chinese patent applications, with 50 valid invention patents and 7 new drug certificates; it has formulated or revised 100 national standards; it has won 4 Chongqing Science and Technology Progress Awards; it has undertaken more than 40 national-level and municipal-level scientific research projects; it has received funding from 3 National Innovation Fund for Small and Medium-sized Technology-based Enterprises; it has participated in 3 National Major New Drug Innovation Projects; multiple products have been rated as China Famous Brand Products, National Key New Products, Chongqing Famous Products, Chongqing Excellent New Products, Chongqing Key New Products, Chongqing Major New Products, and Chongqing High-tech Products.

The enterprise vigorously implements the '10050 Strategy', insists on taking TCM modernization as the core strategic path, vertically integrates the industry chain, horizontally expands business segments, and builds a comprehensive health ecosystem. It focuses on the three strategic resources of talent, technology, and products, and strives to build organizational capabilities that support rapid growth. It inherits the brand essence of 'Wu Shufang', promotes TCM culture, adheres to bottom lines, and operates in compliance.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Xi'er'an Pharmaceutical How Fast Is Hiring Growing? (261 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 102%
  • 2024: Up 90%
  • 2023: Up 109%
  • 2022: Down 77%
Xi'er'an Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Xi'er'an Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Master's 10
Note: How fast is hiring at Chongqing Xi'er'an Pharmaceutical Co., Ltd. growing? Xi'er'an Pharmaceutical2026: 577 openings (down 16%), 2025: 683 openings (up 102%), 2024: 338 openings (up 90%), 2023: 178 openings (up 109%), 2022: 85 openings (down 77%), 2021: 371 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Xi'er'an Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 400%
  • 2024: Flat 0%-
  • 2023: Up 100%
  • 2022: Flat 0%-
Xi'er'an Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Chongqing Xi'er'an Pharmaceutical Co., Ltd. growing? Xi'er'an PharmaceuticalMaster's recruitment over the years: 2025: 10 openings (up 400%), 2024: 2 openings (flat), 2023: 2 openings (up 100%), 2022: 1 openings (flat), 2021: 1 openings. Xi'er'an Pharmaceutical master talent ranking in Chongqing: #68, Xi'er'an Pharmaceutical master salary mostly around 15-50K.

Xi'er'an Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chongqing Xi'er'an Pharmaceutical Co., Ltd.? Based on an analysis of Xi'er'an Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 36.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 16.1%, "Computer/Network/Technology": 9.3%, "Other (R&D and Technical)": 4.5%, "Scientific Research": 2.4%, "Mechanical/Instrumentation": 1%. For reference only.

Xi'er'an Pharmaceutical — What Are the Salaries Like? (795 records)

Manage
Xi'er'an Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 52.3% of roles pay ¥10-20K
Note: salary statistics are based on 795 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chongqing Xi'er'an Pharmaceutical Co., Ltd.?Xi'er'an Pharmaceutical52.3% of positions earn 10-20K, Fresh graduate salary: ¥3.8K。Chongqing salary ranking top 10,销售类 average salary ¥18.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Xi'er'an Pharmaceutical

(More)
Are salaries high at Chongqing Xi'er'an Pharmaceutical Co., Ltd.? We provide: Leasing Manager, Chemistry, Key Account Manager, Sales, Promotion Specialist, Regional Director, Product Manager, Operations, Regional Manager, QA, QC, 临床, Quality, Researcher, Analyst, Security Officer, Provincial Director, Provincial Manager, Finance Specialist, BP. Click to view detailed salary analysis by job.

Xi'er'an Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国中成药企业100强:

  • NO.63 2023中国中成药企业100强 >
  • NO.62 2022中国中成药企业100强 >
  • NO.70 2021中国中成药企业100强 >

Job Category

  • 销售类
    47.9% of total 47.9%
  • 医疗卫生/美容保健类
    36.5% of total 36.5%
  • 经营管理类
    28.5% of total 28.5%
  • 生物/制药/化工/环保类
    16.1% of total 16.1%

Education

  • 本科
    49.6% of total 49.6%
  • 大专
    44.4% of total 44.4%
  • 硕士
    3.3% of total 3.3%
  • 高中
    1.6% of total 1.6%

Experience

  • 3-5年
    36.3% of total 36.3%
  • 5-10年
    23.6% of total 23.6%
  • 不限
    20.3% of total 20.3%
  • 1-3年
    19.7% of total 19.7%
View Detailed Analysis

What does Chongqing Xi'er'an Pharmaceutical Co., Ltd. require? Who is Xi'er'an Pharmaceutical hiring? Xi'er'an Pharmaceutical recruitment: 销售类占比最多占47.9%,其次是医疗卫生/美容保健类占36.5%. What education can get in at Xi'er'an Pharmaceutical? 本科占比最多占49.6%,其次是大专占44.4%. High education required at Xi'er'an Pharmaceutical? 硕士占3.3%. Work experience required at Xi'er'an Pharmaceutical? 3-5年占比最多占36.3%,其次是5-10年占23.6%. Where are the job locations at Xi'er'an Pharmaceutical? 重庆占比最多占43.2%,其次是广安占15.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 10,000万(元)
Legal Representative: 陈洪
Date Established:
Credit Code: 91500117203643727U
Registered Address: 重庆市合川区工业园区希尔安路168号

Partners & Suppliers

山东药玻为希尔安药业提供药用玻璃瓶等内包装材料。 Source
供应商 药品包装材料
九州通是希尔安药业的电商及线下渠道分销商,合作多年。 Source
合作客户 医药商业/分销
康美药业为希尔安药业提供优质中药材原料,双方签订长期供应协议。 Source
供应商 中药材供应
国药控股为希尔安药业提供全国性药品分销服务,覆盖多个省份。 Source
合作客户 医药商业/分销
希尔安药业向重庆九州通供应中成药 Source
合作客户 医药商业/批发

People who follow Xi'er'an Pharmaceutical also follow

Xi'er'an Pharmaceutical Competitors (Similar Companies)

“Serving human pharmaceutical and health undertakings”
“For many consecutive years, it has maintained a leading position in do”
“Pharmaceutical Custom R&D and Manufacturing”
“Semiconductor equipment and parts, electronic manufacturing equipment”
金融 保险 寿险 健康保险
“Top Ten Enterprises in China's Beverage Industry”
“一直以“打造全球卓越游戏内容供应商,培养游戏行业学习型人才”为核心使命”
“Hunan Province Top Ten Pharmaceutical Industry Enterprises”
“Make Taikang a part of people's happy lives”
智能生活 5G技术 通信技术 通信服务
“Mainly engaged in commodity futures brokerage, financial futures broke”
“电连接器、连接器组件及精密智能产品”
“Automotive extended warranty service provider”
V
“Committed to enhancing students' lifelong competitiveness, shaping the”
变速箱 缸体 发动机关键零部件 轮毂

Discover Great Companies, Discover Great Clients

重庆公司名录 重庆“Yubei District”公司名录 重庆“制药/药业”公司名录 重庆“生物科技/生物工程”公司名录 重庆“中药饮片”公司名录 重庆“中成药”公司名录 重庆“原料药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates